Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Titel:
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Auteur:
Loi, S. Michiels, S. Salgado, R. Sirtaine, N. Jose, V. Fumagalli, D. Kellokumpu-Lehtinen, P.-L. Bono, P. Kataja, V. Desmedt, C. Piccart, M.J. Loibl, S. Denkert, C. Smyth, M.J. Joensuu, H. Sotiriou, C.